Hemab Therapeutics Holdings Inc. (COAG)

$34.00 +7.00 (25.93%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 4,094,694
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark. Its products includes (HMB-001), is a bispecific antibody currently in Phase 1/2 clinical development for the prophylactic treatment of Glanzmann thrombasthenia and Phase 2 clinical development for the prophylactic treatment of Factor VII deficiency; and s...

Industry: Biotechnology
Sector: Healthcare
Phone: (617) 553-3952
Address:
101 Main Street, Suite 1220, Cambridge, United States
LongMoneyMovements
LongMoneyMovements Jun. 29 at 6:23 PM
$SLS Destination $15 Leader of the pack $OGN $ODTX $COAG $OCGN $SLS
0 · Reply
LongMoneyMovements
LongMoneyMovements Jun. 29 at 6:19 PM
$OGN $ODTX $COAG $OCGN $SLS
0 · Reply
LongMoneyMovements
LongMoneyMovements Jun. 29 at 6:05 PM
$ODTX $COAG $OCGN $ODTX
0 · Reply
topstockalerts
topstockalerts Jun. 27 at 12:28 AM
$COAG the move looks more deliberate than random.
0 · Reply
justiceforb_85
justiceforb_85 Jun. 26 at 4:37 PM
$COAG great update from the company. Look forward to HMB-002 data in VWD.
0 · Reply
justiceforb_85
justiceforb_85 Jun. 19 at 2:35 AM
$COAG awesome movement today.
0 · Reply
MarketBeat
MarketBeat Jun. 9 at 3:05 AM
https://marketbeat.com/a/8701474/ $COAG Hemab Therapeutics Details Post-IPO Pipeline Push, Sutacimig Phase III Plans
0 · Reply
NVDAMillionaire
NVDAMillionaire Jun. 5 at 5:10 PM
$COAG Really good write-up that perfectly summarizes COAG's present situation. So if you want to bring your COAG knowledge up to date or just discover COAG, this is required reading. https://everyticker.com/quote/COAG/analysis/hemab-s-1-3b-bet-can-a-differentiated-antibody-platform-overcome-thrombosis-risks-to-dominate-rare-bleeding-disorders-nasdaq-coag
0 · Reply
justiceforb_85
justiceforb_85 May. 26 at 9:47 PM
$COAG strong day. Solid funding and good data for sutacimig in GT where they would have a MOAT.
0 · Reply
notreload_ai
notreload_ai May. 26 at 10:02 AM
Jefferies initiates Buy rating on $COAG with $39 target (~50% upside). Sees Hemlibra-like potential in rare bleeding disorders. https://notreload.xyz/xy/jefferies-sees-hemlibra-like-potential-in-hemab-therapeutics-starts-coverage-with-buy-rating/
0 · Reply
Latest News on COAG
Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress

Jun 26, 2026, 9:00 AM EDT - 8 days ago

Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress

Hemab Therapeutics initiated with a Buy at H.C. Wainwright

2026-06-17T10:06:44.000Z - 17 days ago

Hemab Therapeutics initiated with a Buy at H.C. Wainwright

Hemab Therapeutics Holdings Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 9:20 AM EDT - 4 weeks ago

Hemab Therapeutics Holdings Transcript: Jefferies Global Healthcare Conference 2026

Hemab Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

May 27, 2026, 8:00 AM EDT - 5 weeks ago

Hemab Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

Hemab Therapeutics initiated with an Outperform at Evercore ISI

2026-05-26T14:53:50.000Z - 5 weeks ago

Hemab Therapeutics initiated with an Outperform at Evercore ISI

Wedbush bullish on Hemab Therapeutics, initiates with an Outperform

2026-05-26T14:22:55.000Z - 5 weeks ago

Wedbush bullish on Hemab Therapeutics, initiates with an Outperform

Hemab Therapeutics initiated with an Outperform at Wedbush

2026-05-26T12:08:58.000Z - 5 weeks ago

Hemab Therapeutics initiated with an Outperform at Wedbush

Hemab Therapeutics initiated with a Buy at Jefferies

2026-05-26T09:15:41.000Z - 5 weeks ago

Hemab Therapeutics initiated with a Buy at Jefferies

Hemab Therapeutics initiated with a Buy at Goldman Sachs

2026-05-26T08:25:04.000Z - 5 weeks ago

Hemab Therapeutics initiated with a Buy at Goldman Sachs

Hemab Therapeutics Holdings Earnings release: Q1 2026

May 21, 2026, 7:00 AM EDT - 6 weeks ago

Hemab Therapeutics Holdings Earnings release: Q1 2026

Hemab Therapeutics Holdings Quarterly report: Q1 2026

May 21, 2026, 7:00 AM EDT - 6 weeks ago

Hemab Therapeutics Holdings Quarterly report: Q1 2026

Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

May 4, 2026, 4:01 PM EDT - 2 months ago

Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Hemab Therapeutics opens at $27, IPO priced at $18 per share

2026-05-01T16:35:27.000Z - 2 months ago

Hemab Therapeutics opens at $27, IPO priced at $18 per share

Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering

Apr 30, 2026, 6:55 PM EDT - 2 months ago

Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering

Hemab Therapeutics Holdings IPO Registration Document (S-1)

Apr 10, 2026, 4:41 PM EDT - 3 months ago

Hemab Therapeutics Holdings IPO Registration Document (S-1)

LongMoneyMovements
LongMoneyMovements Jun. 29 at 6:23 PM
$SLS Destination $15 Leader of the pack $OGN $ODTX $COAG $OCGN $SLS
0 · Reply
LongMoneyMovements
LongMoneyMovements Jun. 29 at 6:19 PM
$OGN $ODTX $COAG $OCGN $SLS
0 · Reply
LongMoneyMovements
LongMoneyMovements Jun. 29 at 6:05 PM
$ODTX $COAG $OCGN $ODTX
0 · Reply
topstockalerts
topstockalerts Jun. 27 at 12:28 AM
$COAG the move looks more deliberate than random.
0 · Reply
justiceforb_85
justiceforb_85 Jun. 26 at 4:37 PM
$COAG great update from the company. Look forward to HMB-002 data in VWD.
0 · Reply
justiceforb_85
justiceforb_85 Jun. 19 at 2:35 AM
$COAG awesome movement today.
0 · Reply
MarketBeat
MarketBeat Jun. 9 at 3:05 AM
https://marketbeat.com/a/8701474/ $COAG Hemab Therapeutics Details Post-IPO Pipeline Push, Sutacimig Phase III Plans
0 · Reply
NVDAMillionaire
NVDAMillionaire Jun. 5 at 5:10 PM
$COAG Really good write-up that perfectly summarizes COAG's present situation. So if you want to bring your COAG knowledge up to date or just discover COAG, this is required reading. https://everyticker.com/quote/COAG/analysis/hemab-s-1-3b-bet-can-a-differentiated-antibody-platform-overcome-thrombosis-risks-to-dominate-rare-bleeding-disorders-nasdaq-coag
0 · Reply
justiceforb_85
justiceforb_85 May. 26 at 9:47 PM
$COAG strong day. Solid funding and good data for sutacimig in GT where they would have a MOAT.
0 · Reply
notreload_ai
notreload_ai May. 26 at 10:02 AM
Jefferies initiates Buy rating on $COAG with $39 target (~50% upside). Sees Hemlibra-like potential in rare bleeding disorders. https://notreload.xyz/xy/jefferies-sees-hemlibra-like-potential-in-hemab-therapeutics-starts-coverage-with-buy-rating/
0 · Reply
justiceforb_85
justiceforb_85 May. 4 at 4:35 PM
$COAG interesting pipeline.
0 · Reply
topstockalerts
topstockalerts May. 3 at 11:08 PM
Top Gainers $AIOS $CUE $COAG $SOBR $ESPR
0 · Reply
Investor203
Investor203 May. 3 at 7:34 PM
$COAG $CUE i think $VNDA will be $25-$30 soon. Sleeping giant and yes I have over 23,000 shares sofar. Planning to accumulate another 7,000 by EOY.
0 · Reply
topstockalerts
topstockalerts May. 3 at 1:03 PM
Fridays Top Gainers $AIOS $CUE $COAG $SOBR $ESPR
0 · Reply
HugoRush
HugoRush May. 3 at 1:01 PM
$COAG #1 on my wl
0 · Reply
RuneWitcher
RuneWitcher May. 2 at 9:10 PM
$COAG what did this run on?!
0 · Reply
Maryam2000
Maryam2000 May. 2 at 5:27 PM
$COAG 50-60
0 · Reply
Ric_1M
Ric_1M May. 2 at 12:55 PM
$AIOS $CUE $COAG $STEX $TLIH "No pressure, no diamonds." Thomas Carlyle
0 · Reply